Objective: Beneficial effects of IV tissue plasminogen activator (tPA) in acute ischemic stroke are strongly time-dependent. In the Pre-Hospital Acute Neurological Treatment and Optimization of Medical care in Stroke (PHANTOM-S) study, we undertook stroke treatment using a specialized ambulance, the stroke emergency mobile unit (STEMO), to shorten call-to-treatment time.
Keeping the time lapse from symptom onset to therapy of acute ischemic stroke (AIS) patients as short as possible is crucial for achieving good outcome.
1 This is reflected in international guidelines. 2, 3 Several factors can lead to substantial delays, prolonging the call-to-needle time in prehospital 4, 5 as well as in-hospital management. [6] [7] [8] Only in 11% of AIS patients treated with tissue plasminogen activator (tPA) in the International Stroke Thrombolysis Registry (mainly European) was tPA started within the first 90 minutes after symptom onset (of those patients treated within the 3-hour time window). 9 Major efforts have been made to reduce delays in treatment of AIS. [10] [11] [12] [13] Although considerable improvements have been achieved, e.g., by introducing point-of-care coagulation measurement in the emergency room 14 or implementing an all-points alarm, 15 onset-to-treatment times often remain unsatisfactory because prehospital delays are widely unaffected. 12 It may thus be time to rethink the way we organize stroke management in general. The Pre-Hospital Acute Neurological Therapy and Optimization of Medical care in Stroke patients (PHANTOM-S) concept features a newly designed ambulance, the so-called stroke emergency mobile unit (STEMO), which is deployed when patients suspected of having stroke are identified at the dispatch center with a specialized stroke identification interview algorithm. 16 We report the results of the pilot study of an ongoing project to show a relevant reduction in time from emergency call to treatment. 17 This study was focused on feasibility and technical reliability but also assessed preliminary safety and call-to-needle times in patients who received tPA treatment in the prehospital setting.
METHODS Details of the PHANTOM-S study (NCT01382862) have been described previously. 17 The pilot study of the PHANTOM-S was conducted in the emergency medical services system of the city of Berlin during the period from February 8, 2011 to April 30, 2011. Stroke emergency mobile unit. STEMO (see figure 1 ) is designed as a mobile intensive care unit additionally equipped with a CT scanner (CereTom ® 8-slice mobile CT scanner; NeuroLogica ® , Danvers, MA), a point-of-care laboratory (Micros 60, ABX Diagnostics; CoaguChek XS Plus, Roche Diagnostics Germany; and i-STAT Portable Clinical Analyzer, American Screening Corporation, Shreveport, LA), and the telemedicine infrastructure for remote imaging reading as well as video-conferencing support (MEYTEC GmbH, Seefeld, Germany) for evaluating patients with suspected AIS. The CT scanner is locked in a resting position when the vehicle is moving and unlocked for scanning during examination. The CT scanner is run from a small lead-shielded compartment inside the vehicle. Radiation shielding had been calculated beforehand, and technical procedures were tested during a 2-week simulation period before starting patient examinations. STEMO is staffed by a team consisting of a physician with at least 4 years of training in clinical neurology and additional qualification in emergency medicine (neurologist), a paramedic of the fire brigade (similar to Emergency Medical Technician-Paramedic), 18 and a radiographer (radiology technician with at least 2.5 years of clinical experience and specially trained in the use of the CereTom scanner) with additional paramedic qualification (similar to Emergency Medical Technician-Intermediate). 18 The radiographer and the physician (who both stay inside the protected compartment in the vehicle during CT examination) were provided with a dosimeter to record the radiation exposure caused by the CT scanner. The STE-MO is based at a fire brigade station close to the center of Berlin. The operating range was defined by a previously calculated 75% probability to arrive at the scene within 16 minutes and covers more than 1,000,000 inhabitants. In the pilot study, STEMO was supposed to operate from 7:00 AM to 6:30 PM from Monday to Friday every week (11.5 hours daily). The only exception was time required for maintenance, technical upgrades, and several official engagements and presentations.
Dispatcher. The dispatch center of the fire brigade used a previously validated interview algorithm 16 to identify patients with a high probability of stroke within 4 hours after symptom onset or with unknown time of onset. In this case, STEMO was deployed if available. STEMO was assisted by a regular ambulance at all times to avoid delays in the treatment of patients in case a technical problem associated with STEMO occurred.
Patients and procedures. Basic medical care including specific neurologic expertise was offered to all patients who were managed by the STEMO team. Exclusion criteria for STEMO-specific procedures (CT scan and point-of-care laboratory) were age younger than 18 years and possible or known pregnancy. Prehospital diagnostics were started on-site or in the STEMO ambulance. Stroke diagnosis was made clinically by the neurologist. In case of a suspected acute stroke, a brain CT was conducted (with the STEMO in the parking position) after phone consultation with a radiologist. CT was performed only if it was considered to be helpful for a therapeutic decision in the STEMO. After completion of the scan, image data were sent to the radiologist on call via a teleradiology system using bundled 3G standard (universal mobile telecommunications system bandwidth: high-speed packet access). Additional analyses of blood glucose concentration, blood count, international normalized ratio, and electrolytes were performed simultaneously. The radiologist conveyed the CT results to the neurologist on board the STEMO by mobile phone. The final decision for tPA treatment was made by the STEMO physician after a short telephone consultation with the project's senior neurologist. Decision about eligibility for tPA was made on the basis of the drug license except for exclusion of patients older than 80 years (for detailed information, see http://www.strokeforum.com). In case of AIS, patients were admitted to the closest "appropriate hospital" equipped with a stroke unit.
Data collection including follow-up documentation and statistics. Data were collected from prehospital sources (database of the dispatch center and STEMO operation protocols), from hospital sources (medical reports), as well as from a 3-month follow-up telephone survey including a structured interview regarding the modified Rankin scale and living conditions. Data were analyzed only when patients had given informed consent for the use and publication of individual data.
If patients were unavailable at the 3-month follow-up, the registration office was contacted to ascertain whether the patient had survived. All data are presented in a descriptive manner and The stroke emergency mobile unit with CT scanner on board
Note the CT scanner in the back of the cabin and the separated shielded workstation on the right behind the door.
the analysis was performed with SPSS Statistics 19 statistical software (IBM Corporation, Armonk, NY).
Ethics approval. The study was approved by the Data Protection Commissioner and the Ethics Committee of the Charité Universitätsmedizin. For the new setting of a mobile CT scanner and prehospital thrombolysis, CT examination and specific stroke treatment could be offered only to patients who were able to give informed consent for STEMO-specific procedures personally or by a legally authorized representative. Data were analyzed only if patients gave informed consent for the use and publication of the individual data.
RESULTS Calculation of times in regular care. To provide an estimate of times to treatment in regular care, we refer to the procedure times that were used in the power calculation for the prospective controlled study (NCT01382862 Technical and conceptual reliability. Noncontrast brain CT was performed in 64 patients (83%), and an additional cranial CT angiography in 1 patient with suspected proximal middle cerebral artery occlusion. Eight brain CT examinations (12%) displayed motion artifacts with moderately impaired reading quality in 5 (8%) as stated by the radiologist. No technical failures occurred in the vehicle itself, the point-of-care laboratory, or the other medical instruments except for 1 case of CT dysfunction. Because of a CT motion blockage, 1 patient had to be transported by a regular ambulance to the nearest stroke unit (accompanied by the physician) where the patient received tPA after CT examination. In 2 cases, the CT image transmissions were delayed (.5 minutes but both ,15 minutes) because of temporarily low transmission rates in the mobile telecommunication system. The radiation levels recorded by the dosimeters remained within normal limits over the entire period.
Diagnosis and treatment of patients. On the basis of medical history and neurologic examination, the neurologist established a prehospital diagnosis of stroke in 56 patients and TIA in 5 patients. This prehospital diagnosis was confirmed in 53 cases (87%) (45 AIS, 7 TIAs, 1 hemorrhagic stroke) by the final in-hospital diagnosis. The other 8 patients were diagnosed in hospital with headache (3 patients), infection (2 patients), dysarthria with unknown etiology (1 patient), intoxication (1 patient), and brain tumor (1 patient). However, 14 of 16 patients (88%) with a prehospital provisional nonstroke diagnosis had a final nonstroke diagnosis in hospital. The other 2 patients had an in-hospital diagnosis of subarachnoidal hemorrhage (1 patient) and TIA (1 patient). Eighty-eight percent (68 patients) eventually had a neurologic disorder; these disorders consisted ) in all AIS patients treated with tPA. Four patients (17%) were treated within 60 minutes. Two patients (8%) treated with tPA experienced an intracranial hemorrhage during the first 7 days after stroke onset. Whereas clear neurologic deterioration was observed in 1 patient, the other patient developed a mild somnolence and the hemorrhage was detected in regular follow-up imaging. This patient (88 years old) died in the hospital with sepsis on day 16. One additional patient who had a prehospital diagnosis of acute stroke with sudden onset of dysarthria and weakness in one arm was treated with tPA, but was finally diagnosed with sepsis; no side effects of treatment occurred in this patient. The reasons for not treating with tPA in 22 patients with AIS included onset-totherapy decision time of more than 4.5 hours (n 5 13), severe disability pre-onset (n 5 2), anticoagulation (n 5 2), no disabling deficit at the time of therapy decision (n 5 1), a tumor with uncertain significance (n 5 1), and symptoms of severe stroke with fixed gaze deviation and hemiplegia (n 5 3).
After ambulance transport, no other serious adverse events were recorded in stroke or nonstroke patients during the first 7 days or up to hospital discharge. The clinical characteristics, the time parameters of the prehospital stroke treatment, and functional outcome of patients with AIS are shown in the table. Telephone follow-up data of all AIS patients with thrombolytic treatment are summarized in the table. Of those patients, 43% reached a modified Rankin scale score of 0 or 1. DISCUSSION The results of our study indicate that specific stroke management including diagnostic setup and thrombolytic treatment is feasible in the prehospital setting. Using a stroke identification algorithm at the dispatching level, a specialized stroke ambulance can be sent specifically to patients with acute neurologic diseases. With the exception of 1 CT failure, the mobile technology was stable and thrombolytic treatment could be applied to a high proportion of patients. Compared with previously collected control data, the new approach promises a relevant time saving in call-to-needle times. By accelerating the diagnostic setup, onset-to-needle times were less than 90 minutes in 48% of our patients compared with 11% of the patients treated within the 3-hour time window in the International Stroke Thrombolysis Registry. 9 Albeit small, our pilot study has not raised safety concerns.
The idea of a specialized stroke emergency vehicle equipped with a CT scanner 19 was first realized in the Mobile Stroke Unit project of the University of Saarland, Germany, and the results of a controlled study comprising 100 patients (53 in the active cohort with 12 prehospital tPA treatments) were recently published. 20, 21 The time from call to treatment was substantially reduced by prehospital thrombolysis compared with regular care. In comparison to the Mobile Stroke Unit project, STEMO was deployed in a different population setting (urban area in contrast to a more rural area) with a high number of patients potentially eligible for treatment. In contrast to the Mobile Stroke Unit project, an additional emergency physician was called to the stroke emergencies only in case of vital threat (and therefore to be at the scene at the same time), and radiology was performed via teleradiology instead of having a radiologist on board of the vehicle. In addition, patients with acute emergencies were transported in the STEMO to the hospital whereas the transport was done by a regular ambulance in the Mobile Stroke Unit project.
Our series of prehospital tPA treatments seems encouraging. Although tPA was restricted to patients able to give informed consent, we managed to treat 23 patients in a short time period of 52 days. The high frequency of specific stroke treatment is relevant when taking into account the significant financial and personnel efforts of such a new infrastructure.
Two studies have reported the use of specialized mobile medical services in emergency medicine, 22, 23 one for myocardial infarction and one for stroke care by a mobile intensive care unit. Both suggested faster and more reliable care for patients compared with standard procedures but the mobile stroke intensive care unit did not provide prehospital brain imaging or thrombolytic therapy.
So far, the results have not raised safety concerns that prehospital treatment with tPA might lead to a higher rate of serious complications such as intracranial hemorrhage or death compared with in-hospital use of tPA. 24, 25 This is in agreement with previous publications that did not report higher rates of secondary hemorrhage when tPA was started in smaller hospitals and transferral to a referral stroke center was initiated immediately ("drip and ship"). [26] [27] [28] [29] [30] The present study has limitations. Given that the study was designed as a pilot and feasibility study, our sample size is too small to provide sufficient evidence for safety. With previously collected control data only, any statement regarding effective time saved should be made with caution. Hence, within the framework of PHANTOM-S, a controlled study is currently underway comparing the effects of prehospital and conventional stroke management between randomly assigned calendar periods with and without STEMO availability. 17 The new concept requires substantial human and financial resources that need to be analyzed in a health economy evaluation. Whether such a concept is more appropriate for rural or urban settings is under debate. However, the new approach of prehospital stroke management may offer additional benefits such as a prehospital triage with directed admission to the most appropriate hospital. 20 It may also create a new infrastructure for research of innovative stroke treatments. STEMO combines specialized equipment and a highly qualified stroke team, both available in a very early time window after stroke onset.
The feasibility and technical reliability of prehospital acute stroke work-up including thrombolytic treatment before hospital arrival has been shown. In addition, our results indicate that STEMO may be effective in the reduction of call-to-treatment time. 
